Cargando…
Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis
BACKGROUND: Central nervous system (CNS) histoplasmosis is a life-threatening condition, and represents a diagnostic and therapeutic challenge. Although CSF (1,3)-β-d-glucan (CSF BDG) is available as a biologic marker for diagnosis of fungal meningitis, there are limited data on its use for diagnosi...
Autores principales: | Myint, Thein, Bloch, Karen, Raymond-Guillen, Luke, Wheat, L Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631824/ http://dx.doi.org/10.1093/ofid/ofx163.013 |
Ejemplares similares
-
Improvement in Diagnosis of Histoplasma Meningitis by Combined Testing for Histoplasma Antigen and Immunoglobulin G and Immunoglobulin M Anti-Histoplasma Antibody in Cerebrospinal Fluid
por: Bloch, Karen C, et al.
Publicado: (2018) -
Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014) -
Diagnosis of Histoplasmosis Using the MVista Histoplasma Galactomannan Antigen Qualitative Lateral Flow–Based Immunoassay: A Multicenter Study
por: Abdallah, Wassim, et al.
Publicado: (2021) -
The Eng1 β-Glucanase Enhances Histoplasma Virulence by Reducing β-Glucan Exposure
por: Garfoot, Andrew L., et al.
Publicado: (2016) -
Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-d-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report
por: Ceccarelli, Giancarlo, et al.
Publicado: (2016)